Everand Logo

Welcome to Everand!

  • STAT

    LISTEN: CRISPR upheaval, Celgene’s chutzpah, and canine genomics

    Is genome editing harder than anyone thought? Will no one weep for Celgene? And is it time to sequence your dog? Find out on this week's episode of "The Readout…
    by Damian Garde and Rebecca Robbins Jan 24, 2019 1 minute

    Is genome editing harder than anyone thought? Will no one weep for Celgene? And is it time to sequence your dog?

    We discuss

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    STAT+: Akili, Maker Of A Video Game To Treat ADHD, To Be Acquired For $34 Million
    Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Merck Deal, Weight Loss Drugs, And Lots More
    Merck has struck a $1.3 billion deal to buy Eyebiotech, a move that would push the big drugmaker into the large and growing market for eye care.
    STAT1 min read
    Opinion: STAT+: Unmasking The ‘Centricity’ Illusion In Clinical Trials
    The glacial pace of change in mechanistic but essential areas of clinical trials undermines the biopharma industry's claims of progress and compassion.

    Related Books & Audiobooks